Information:
Fel:
ID
34559
Beskrivning
An Observational Study of RoActemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Non-Biological DMARDs; ODM derived from: https://clinicaltrials.gov/show/NCT01617005
Länk
https://clinicaltrials.gov/show/NCT01617005
Nyckelord
Versioner (1)
- 2019-01-19 2019-01-19 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
19 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Rheumatoid Arthritis NCT01617005
Eligibility Rheumatoid Arthritis NCT01617005
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT01617005
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
adult patients, >18 years of age
boolean
ID.2
Item
moderate to severe active rheumatoid arthritis (eular criteria)
boolean
ID.3
Item
inadequate response to dmards
boolean
ID.4
Item
initiating treatment with roactemra according to summary of product characteristics (spc)
boolean
ID.5
Item
pregnant or lactating females
boolean
ID.6
Item
rheumatic autoimmune disease other than rheumatoid arthritis
boolean
ID.7
Item
prior history or current inflammatory joint disease other than rheumatoid arthritis
boolean
ID.8
Item
previous treatment with any biological drug used in the treatment of rheumatoid arthritis
boolean
ID.9
Item
previous treatment with roactemra/actemra
boolean
ID.10
Item
any contraindication to treatment with roactemra/actemra
boolean